Shares of HIMS experienced a dramatic drop today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending HIMS's stock price plummeting by nearly fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that